Immuno-Oncology

Blogs

Best Pharma Innovations of 2024, According to TIME

Spatial Biology in Action: Transforming the Future of Drug Discovery and Development

November 21, 2024
Biotech News

Ivonescimab Looking to Rival Merck’s Keytruda in NSCLC with Phase III Trial Enrollment Complete
Biotech Blogs

The Challenges and Promise of CAR T-Cell Therapy in Oncology
Blogs

World Cancer Research Day 2024: New Cancer Drugs and Clinical Milestones
Approvals News

Tecentriq Hybreza Cancer Immunotherapy Gets FDA Nod as Genentech Expands Subcutaneous Options

Immune Cell-mediated Cytotoxicity: Single-cell Insights Using Droplets and Image Cytometry

June 18, 2024
Life Science Podcast

Developing Conditionally Active Antibodies Targeting the Tumor Microenvironment ft. John K. Celebi, CEO, Sensei Bio – Xtalks Life Science Podcast Ep. 156
Approvals News

ImmunityBio’s Cancer Immunotherapy Anktiva Wins FDA Approval, Boasting a “Triangular Offense”

Enhanced Multiplex IHC Technology for Precision Oncology

February 22, 2024

Immunotherapy for Pancreatic Cancer: Peptidic Targeting of a Tumor-Specific Glycan

January 31, 2024
Blogs

Advancing CAR T Cell Therapies in Immuno-Oncology – Featuring Dr. Paul Rennert, CEO, Aleta Biotherapeutics – Xtalks Life Science Podcast Ep. 131
Approvals News

Roche’s Columvi Becomes Second Bispecific Approved for Diffuse Large B-Cell Lymphoma
Approvals News

Epkinly (Epcoritamab) Approved as First Bispecific Antibody for Most Common Non-Hodgkin’s Lymphoma

How Humanized Mouse Models Enforce Preclinical Studies in Immuno-Oncology

May 30, 2023
Blogs

Interview About New Follicular Lymphoma Drug with Genentech’s Dr. Ginna Laport